Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study

BACKGROUND AND OBJECTIVES: Subcutaneous immunoglobulin (SCIG) therapy is becoming increasingly popular as self-administration is possible because intravenous access is unnecessary, and there is a lower frequency of systemic adverse events. The aim of this study was to evaluate the shifting from intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vultaggio, Alessandra, Azzari, Chiara, Milito, Cinzia, Finocchi, Andrea, Toppino, Claudia, Spadaro, Giuseppe, Trizzino, Antonino, Baldassarre, Martire, Paganelli, Roberto, Moschese, Viviana, Soresina, Annarosa, Matucci, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335091/
https://www.ncbi.nlm.nih.gov/pubmed/25672929
http://dx.doi.org/10.1007/s40261-015-0270-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335091/
https://www.ncbi.nlm.nih.gov/pubmed/25672929
http://dx.doi.org/10.1007/s40261-015-0270-1

Ejemplares similares